Last reviewed · How we verify

NCT05866081

Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative

Recruiting now NA Last updated 15 December 2025
What this trial tests

NA trial testing Standard of care stent placement in Stone, Kidney in 792 participants. Currently enrolling.

Timeline
1 June 2023
Primary endpoint
1 May 2026
1 May 2026

Quick facts

Lead sponsorUniversity of Michigan
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment792
Start date1 June 2023
Primary completion1 May 2026
Estimated completion1 May 2026
Sites16 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Michigan

Who can join

18 and older, any sex, with Stone, Kidney or Stone Ureter. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multicenter prospective trial with randomized and observational cohorts assessing patient-reported outcomes and unplanned healthcare utilization following ureteroscopic treatment of renal and ureteral stones, with placement versus omission of a ureteral stent. Eligible participants in the randomization trial will be randomized to ureteroscopy with stent placement or stent omission. Eligible participants that consent to the observational only cohort will complete surveys and the treating physicians will decide the treatment options for the participants. The study team hypothesizes that: * Pain interference change from pre-surgery to Day 7-10 will differ between the two treatment arms. This hypothesis will be evaluated separately in the randomized and observational cohorts. * Unplanned healthcare utilization in the treatment arms will have different unplanned healthcare utilization ranks leading to a win proportion significantly higher or lower than 0.5 in the stent omission arm compared to the stent placement arm. This hypothesis will be evaluated separately in the randomized and observational cohorts.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Stent Omission after Ureteroscopy and Lithotripsy (SOUL) in the Michigan Urological Surgery Improvement Collaborative (MUSIC): study protocol for a pragmatic prospective combined randomized and observational clinical trial.
    Becker REN, Daignault-Newton S, Shoemaker E, Sitek D, et al · · 2024 · cited 7× · PMID 39633425 · DOI 10.1186/s13063-024-08587-8
  2. Rationale and protocol for a prospective clinical trial enrollment improvement hybrid study within a trial.
    Lewicki P, Clark S, Shoemaker E, Wang B, et al · · 2025 · PMID 41050879 · DOI 10.1016/j.conctc.2025.101548
  3. Stent Omission after Ureteroscopy and Lithotripsy (SOUL) in the Michigan Urological Surgery Improvement Collaborative (MUSIC): Study Protocol for a Pragmatic Prospective Combined Randomized and Observational Clinical Trial
    Becker RE, Daignault-Newton S, Shoemaker E, Sitek D, et al · · 2024 · DOI 10.21203/rs.3.rs-4613403/v1

Verify or expand the search:

Other recruiting trials for Stone, Kidney

Currently open trials in the same condition.

Other University of Michigan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05866081.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing